(Q41611084)

5 October 2017

1 reference

title

Brain energy metabolizing enzymes in Alzheimer's disease: alpha-ketoglutarate dehydrogenase complex and cytochrome oxidase (English)

1 reference

5 October 2017

0 references

Kish SJ

1

1 reference

PubMed ID

9329693

5 October 2017

language of work or name

English

0 references

publication date

1 September 1997

1 reference

Annals of the New York Academy of Sciences

5 October 2017

1 reference

5 October 2017

826

1 reference

5 October 2017

218-228

1 reference

Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

5 October 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Synaptic and non-synaptic mitochondria from rat brain: isolation and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Reduced Activities of Thiamine-Dependent Enzymes in the Brains and Peripheral Tissues of Patients With Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Abnormality of the alpha-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Brain protein and alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Brain thiamine, its phosphate esters, and its metabolizing enzymes in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Thiamine therapy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Accumulation of amyloid precursor protein-like immunoreactivity in rat brain in response to thiamine deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Mutation analysis of the chromosome 14q24.3 dihydrolipoyl succinyltransferase (DLST) gene in patients with early-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Immunoreactive levels of alpha-ketoglutarate dehydrogenase subunits in Friedreich's ataxia and spinocerebellar ataxia type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Cytochrome oxidase: an endogenous metabolic marker for neuronal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Reduced platelet cytochrome c oxidase activity in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

No evidence for reduced thrombocyte cytochrome oxidase activity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Na+/Ca2+ exchange activity is increased in Alzheimer's disease brain tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Brain Cytochrome Oxidase in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Mitochondrial function in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Analyses of energy metabolism and mitochondrial genome in post-mortem brain from patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Electron transport chain defects in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Decreased cytochrome-c oxidase activity and lack of age-related accumulation of mitochondrial DNA deletions in the brains of schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Diffuse prolonged depression of cerebral oxidative metabolism following concussive brain injury in the rat: a cytochrome oxidase histochemistry study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Chronic sodium azide treatment impairs learning of the Morris water maze task

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

Cytochrome Oxidase Inhibition: A Novel Animal Model of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48473.X

10.1111/J.1749-6632.1997.TB48473.X

21 January 2018

Identifiers

DOI

1 reference

5 October 2017

1 reference

PubMed ID

9329693